Pharma company Indivior has tapped full-service creative and digital agency McKinney as its US Agency Of Record (AOR) for the US Addiction Sciences and US Behavioral Health business units. The company is known for manufacturing drugs that help treat substance abuse disorders.  

Three years ago, the drugmaker pled guilty to a felony charge brought by the U.S. Department of Justice for false statements related to the marketing of the film version of Suboxone and agreed to pay $600 million to resolve criminal and civil investigations by the DOJ. The company was owned by Reckitt Benckiser before being spun off as a public UK company in 2014.  

The company previously worked with Klick Health, Area 23 and Havas Tonic on the account. 

“This is a significant win for our McKinney Health group,” said Joe Maglio, CEO of McKinney. “This establishes McKinney Health as a key player in the industry and serves as a proof of concept for our innovative approach.” 

Led by healthcare industry veteran Michael McNamara, McKinney Health launched in June 2022, and has since grown from six to over 40 health-specific staff.  

In addition to Indivior, McKinney Health has worked with Zhou Nutrition and Alcon Pharmaceuticals, and is consulting on other McKinney brands in the wellness space, such as Stop & Shop and Blue Diamond Growers.